Book contents
- Frontmatter
- Contents
- Editorial board
- Acknowledgements
- List of contributors
- Introduction
- Part I
- Part II
- 25 Ethical principles for medical research involving human subjects
- 26 The Belmont Report: ethical principles and guidelines for the protection of human subjects of research
- 27 ICH Good Clinical Practice Guideline
- 28 Governance arrangements for NHS research ethics committees
- 29 The research governance framework for health and social care
- 30 EU Clinical Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations, and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
- 31 European Convention on human rights and biomedicine (ETS 164) and additional protocol on the prohibition of cloning human beings
- 32 Good research practice
- 33 Research: the role and responsibilities of doctors
- 34 Guidelines for company-sponsored safety assessment of marketed medicines (SAMM)
- 35 Guidelines for medical experiments in non-patient human volunteers
- 36 Facilities for non-patient volunteer studies
- 37 Multi-centre research in the NHS – the process of ethical review when there is no local researcher
- 38 Medical devices regulations and research ethics committees
- 39 NHS indemnity – arrangements for clinical negligence claims in the NHS
- 40 Clinical trial compensation guidelines
- 41 Research ethics: guidance for nurses involved in research or any investigative project involving human subjects
- 42 Ethical principles for conducting research with human participants
- 43 Statement of ethical practice
- 44 Human tissue and biological samples for use in research
- 45 Transitional guidelines to facilitate changes in procedures for handling ‘surplus’ and archival material from human biological samples
- 46 Code of practice on the use of fetuses and fetal material in research and treatment (extracts from the Polkinghorne Report)
- 47 Guidance on the supply of fetal tissue for research, diagnosis and therapy
- 48 Guidance on making proposals to conduct gene therapy research on human subjects (seventh annual report – section 1)
- 49 Report on the potential use of gene therapy in utero
- 50 Human fertilisation and embryology authority – code of practice (extracts)
- 51 Guidelines for researchers – patient information sheet and consent form
- 52 ABPI Guidance note – patient information and consents for clinical trials
- 53 The protection and use of patient information (HSG(96)18/LASSL(96)5)
- 54 The Caldicott Report on the review of patient-identifiable information – executive summary December 1997
- 55 Personal information in medical research
- 56 Use and disclosure of medical data – guidance on the Application of the Data Protection Act, 1998, May 2002
- 57 Guidelines for the ethical conduct of medical research involving children
- 58 Clinical investigation of medicinal products in the paediatric population
- 59 Guidelines for researchers and for ethics committees on psychiatric research involving human participants – executive summary
- 60 The ethical conduct of research on the mentally incapacitated
- 61 Volunteering for research into dementia Alzheimer's Society
- 62 Knowledge to care: research and development in hospice and specialist palliative care – executive summary
- 63 NUS guidelines for student participation in medical experiments and guidance for students considering participation in medical drug trials
- 64 Ethical considerations in HIV preventive vaccine research
- 65 2002 international ethical guidelines for biomedical research involving human subjects
- 66 1991 international guidelines for ethical review of epidemiological studies
- 67 Operational guidelines for ethics committees that review biomedical research
- 68 Registration of an institutional review board (IRB) or independent ethics committee (IEC)
- 69 International guidelines on bioethics (informal listing of selected international codes, declarations, guidelines etc. on medical ethics/bioethics/health care ethics/human rights aspects of health)
- Index
49 - Report on the potential use of gene therapy in utero
Published online by Cambridge University Press: 08 January 2010
Edited by
Book contents
- Frontmatter
- Contents
- Editorial board
- Acknowledgements
- List of contributors
- Introduction
- Part I
- Part II
- 25 Ethical principles for medical research involving human subjects
- 26 The Belmont Report: ethical principles and guidelines for the protection of human subjects of research
- 27 ICH Good Clinical Practice Guideline
- 28 Governance arrangements for NHS research ethics committees
- 29 The research governance framework for health and social care
- 30 EU Clinical Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations, and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
- 31 European Convention on human rights and biomedicine (ETS 164) and additional protocol on the prohibition of cloning human beings
- 32 Good research practice
- 33 Research: the role and responsibilities of doctors
- 34 Guidelines for company-sponsored safety assessment of marketed medicines (SAMM)
- 35 Guidelines for medical experiments in non-patient human volunteers
- 36 Facilities for non-patient volunteer studies
- 37 Multi-centre research in the NHS – the process of ethical review when there is no local researcher
- 38 Medical devices regulations and research ethics committees
- 39 NHS indemnity – arrangements for clinical negligence claims in the NHS
- 40 Clinical trial compensation guidelines
- 41 Research ethics: guidance for nurses involved in research or any investigative project involving human subjects
- 42 Ethical principles for conducting research with human participants
- 43 Statement of ethical practice
- 44 Human tissue and biological samples for use in research
- 45 Transitional guidelines to facilitate changes in procedures for handling ‘surplus’ and archival material from human biological samples
- 46 Code of practice on the use of fetuses and fetal material in research and treatment (extracts from the Polkinghorne Report)
- 47 Guidance on the supply of fetal tissue for research, diagnosis and therapy
- 48 Guidance on making proposals to conduct gene therapy research on human subjects (seventh annual report – section 1)
- 49 Report on the potential use of gene therapy in utero
- 50 Human fertilisation and embryology authority – code of practice (extracts)
- 51 Guidelines for researchers – patient information sheet and consent form
- 52 ABPI Guidance note – patient information and consents for clinical trials
- 53 The protection and use of patient information (HSG(96)18/LASSL(96)5)
- 54 The Caldicott Report on the review of patient-identifiable information – executive summary December 1997
- 55 Personal information in medical research
- 56 Use and disclosure of medical data – guidance on the Application of the Data Protection Act, 1998, May 2002
- 57 Guidelines for the ethical conduct of medical research involving children
- 58 Clinical investigation of medicinal products in the paediatric population
- 59 Guidelines for researchers and for ethics committees on psychiatric research involving human participants – executive summary
- 60 The ethical conduct of research on the mentally incapacitated
- 61 Volunteering for research into dementia Alzheimer's Society
- 62 Knowledge to care: research and development in hospice and specialist palliative care – executive summary
- 63 NUS guidelines for student participation in medical experiments and guidance for students considering participation in medical drug trials
- 64 Ethical considerations in HIV preventive vaccine research
- 65 2002 international ethical guidelines for biomedical research involving human subjects
- 66 1991 international guidelines for ethical review of epidemiological studies
- 67 Operational guidelines for ethics committees that review biomedical research
- 68 Registration of an institutional review board (IRB) or independent ethics committee (IEC)
- 69 International guidelines on bioethics (informal listing of selected international codes, declarations, guidelines etc. on medical ethics/bioethics/health care ethics/human rights aspects of health)
- Index
Summary
Background
Since gene therapy was first attempted in1989, there have been over 300 clinical protocols approved world wide. 30 research trials in patients have been considered in the UK by the Gene Therapy Advisory Committee (GTAC) established in 1993 to review such work [1].
There is a wide consensus that, at present, gene therapy should be restricted to attempts to modify somatic (body) cells so that changes will not be passed to successive generations. GTAC has confirmed that its view remains that gene modification of the germ line, where effects could be transmitted to offspring, should not yet be attempted.
To date, all but two of the trials of somatic gene therapy considered by GTAC have been intended to be performed in adults or young persons over 16 years. The two exceptions were in young children born with inherited single gene disorders, Hurlers Disease and Severe Combined Immuno-Deficiency (SCID), where it may be possible to correct the gene deficiency before serious or life threatening symptoms develop.
However in many genetic disorders it may not be possible to use such potential therapies after birth. In some disorders the damage is already done before birth and there may be good clinical reasons to intervene in utero to try and correct the genetic damage.
Interventions in utero are not new. Surgical procedures are used to correct the accumulation of fluid in the bladder or chest; steroid drugs can be infused into the developing fetus and transfusion of blood or platelets directly into the fetus are established procedures.
[…]
- Type
- Chapter
- Information
- Manual for Research Ethics CommitteesCentre of Medical Law and Ethics, King's College London, pp. 329 - 332Publisher: Cambridge University PressPrint publication year: 2003
- 1
- Cited by